SOUTH SAN FRANCISCO, Calif. /PRNewswire/ -- Biocompare, the leading online information resource for the life sciences, has added another content hub to its burgeoning Future Lab program with the introduction of Future Lab: Antibody-Based Therapeutic Discovery and Development sponsored by Shimadzu.

Future Lab is an interactive information resource designed to showcase the latest breakthroughs, trends, news, and products within specific scientific niches. Since their launch in 2016, the Future Lab content hubs have developed a devoted global audience. The hubs are updated weekly, and regular alerts drive engagement with registered users.

Like our other Future Labs, the Antibody-Based Therapeutic Discovery and Development Future Lab will deliver information in an easily accessible format—in this case, helping researchers stay abreast of the latest enabling methods and applications in antibody therapeutic discovery and development. Topics to be covered include discovery, candidate characterization, and pilot development.

Previous Future Labs have focused on other fundamental topics in life science research including Genetic Analysis, Live Cell Imaging, Protein Production, Immunodetection, Cell Culture, Liquid Handling, Next Generation Sequencing, Flow Cytometry, and Biopharmaceutical Analysis.

"We are really excited to have developed this platform to allow the more than 2.4 million scientists who visit Biocompare each year to consume content in a much more engaging environment. This fully supports Biocompare's mission to educate scientists in the latest technology while providing the tool provider community a unique and novel way to engage with our audience," says Joan Boyce, VP & GM of Biocompare.